Athira Pharma's market cap is currently $17.34M. The company's EPS TTM is $-2.849; its P/E ratio is ―; Athira Pharma is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -969.00K	$ -1.05M	$ -479.00K	$ -2.00M	$ 0.00
Operating Income	$ -125.47M	$ -104.02M	$ -64.02M	$ -20.00M	$ -5.45M
EBITDA	$ -116.70M	$ -94.59M	$ -54.37M	$ -19.01M	$ -4.82M
Net Income	$ -117.67M	$ -87.26M	$ -54.37M	$ -18.63M	$ -4.70M
Balance Sheet
Cash & Short-Term Investments	$ 147.42M	$ 200.34M	$ 253.76M	$ 184.68M	$ 2.06M
Total Assets	$ 160.25M	$ 258.15M	$ 332.01M	$ 279.56M	$ 2.19M
Total Debt	$ 1.58M	$ 1.91M	$ 1.92M	$ 1.00M	$ 1.55M
Net Debt	$ -89.00M	$ -94.06M	$ -108.62M	$ -59.63M	$ -503.00K
Total Liabilities	$ 30.06M	$ 23.02M	$ 10.92M	$ 5.28M	$ 21.91M
Stockholders' Equity	$ 130.19M	$ 235.14M	$ 321.08M	$ 274.28M	$ -19.72M
Cash Flow
Free Cash Flow	$ -101.06M	$ -73.61M	$ -44.67M	$ -26.43M	$ -3.71M
Operating Cash Flow	$ -100.75M	$ -72.47M	$ -43.10M	$ -24.11M	$ -3.71M
Investing Cash Flow	$ 95.09M	$ 57.66M	$ -4.08M	$ -210.07M	$ 1.51M
Financing Cash Flow	$ 493.00K	$ 654.00K	$ 97.09M	$ 292.75M	$ 946.00K

Currency in USD

Athira Pharma Earnings and Revenue History

Income Statement >

Athira Pharma Debt to Assets

Balance Sheet >

Athira Pharma Cash Flow

Cash Flow >

Athira Pharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing